A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute exacerbation of interstitial pneumonia

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):343-9.

Abstract

Background: Direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) might be beneficial for treating acute exacerbation (AE) of interstitial pneumonia (IP). Venovenous extracorporeal membranous oxygenation (VV-ECMO) is an emerging tool to avoid ventilator-induced lung injury. This is a report presenting the first three patients with AE of IP treated with a combined therapy of PMX-DHP and VV-ECMO.

Case presentation: Patient 1 was a 68-year-old male with acute interstitial pneumonia, patient 2 a 67-year-old male with AE of idiopathic pulmonary fibrosis, and patient 3 a 61-year-old female with AE of collagen vascular disease-associated interstitial pneumonia. All patients were severely hypoxemic and required mechanical ventilation. A combined therapy using PMX-DHP and VV-ECMO was initiated with support of intravenous corticosteroids and antibiotics. Radiological findings, oxygenation and laboratory findings markedly improved and all patients survived without severe complications.

Conclusion: A combined therapy of PMX-DHP and VV-ECMO might be a therapeutic option for AE of IP.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Combined Modality Therapy
  • Disease Progression
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Hemoperfusion / methods*
  • Humans
  • Idiopathic Pulmonary Fibrosis / diagnosis
  • Idiopathic Pulmonary Fibrosis / therapy*
  • Lung Diseases, Interstitial / diagnosis
  • Lung Diseases, Interstitial / therapy*
  • Male
  • Middle Aged
  • Polymyxin B / therapeutic use*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Polymyxin B